Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Has $1.26 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group cut its position in Cardinal Health, Inc. (NYSE:CAH) by 22.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,635 shares of the company’s stock after selling 3,045 shares during the period. Cardinal Health accounts for about 0.7% of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s investment portfolio, making the stock its 23rd biggest position. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s holdings in Cardinal Health were worth $1,258,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp boosted its position in Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after buying an additional 627,253 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after purchasing an additional 191,568 shares in the last quarter. Amundi lifted its position in shares of Cardinal Health by 5.5% during the fourth quarter. Amundi now owns 2,116,291 shares of the company’s stock worth $259,309,000 after purchasing an additional 110,605 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Cardinal Health by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company’s stock worth $179,653,000 after purchasing an additional 44,386 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $126.87 on Thursday. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The company has a market capitalization of $30.65 billion, a PE ratio of 23.67, a PEG ratio of 1.49 and a beta of 0.66. The company has a 50 day moving average price of $125.99 and a two-hundred day moving average price of $119.14.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CAH shares. Argus set a $148.00 target price on shares of Cardinal Health in a research report on Tuesday, February 4th. Mizuho started coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 target price on the stock. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Finally, Citigroup upped their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.